GlassScriptPhysician profile
Anna Bliss Hyde
NPI 1528527868
$1,884.58
in general payments reported to CMS, 2019-2025
19 companies · $738 in 2025
The $738 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.96 · 2022: $449 · 2023: $201 · 2024: $478 · 2025: $738.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $993 · Travel and Lodging: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $992.51 |
| Travel and Lodging | $425.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $738.44 | 2025 | Linq II, Micra, Affera Mapping System |
| Boston Scientific Corporation | $227.97 | 2021-2024 | Watchman Flx, Watchman Access System |
| Heartflow, INC. | $172.15 | 2022-2023 | Ffrct |
| Edwards Lifesciences Corporation | $124.94 | 2022 | |
| Amgen INC. | $93.78 | 2023-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $60.58 | 2023-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $57.73 | 2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.57 | 2024 | Jardiance |
| Pfizer INC. | $46.24 | 2024 | |
| Novo Nordisk INC | $41.37 | 2024 | Ozempic, Rybelsus |
| Abbott Laboratories | $37.43 | 2023 | Cardiomems, Architect |
| Novartis Pharmaceuticals Corporation | $35.36 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.84 | 2023-2024 | |
| Impulse Dynamics (USA) INC. | $34.72 | 2023 | Optimizer |
| Inspire Medical Systems, INC. | $33.19 | 2024 | Inspire |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $24.38 | 2024 | Accucinch |
| Astrazeneca Pharmaceuticals LP | $22.56 | 2024 | |
| Biosense Webster, INC. | $21.78 | 2024 | Qdot Micro Catheter, Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.55 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Hyde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.